chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Under 18 years of age was given first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under 18 years of age was given first dose) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under 18 years of age was given first dose). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Under 18 years of age was given first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: This report refers to a case of Product Administered to Patient of Inappropriate Age for mRNA-1273 (Lot number: 018B21A) with no associated AEs.
temp to 106 confirmed in ER; fever started 12 hr p/vax;
Patient was given the MMR vaccine while pregnant. Patient did not inform administering provider of pregnancy. Patient is in her first trimester.
SWELLING,REDNESS,TENDERNESS, ITCHINESS,SORENESS 8 DAYS AFTER VACCINATION.
Discharge Provider: MD Primary Care Provider: MD Admission Date: 2/12/2023 Discharge Date:  February 16th 2023   PRESENTING PROBLEM: Shortness of breath Altered mental status, unspecified altered mental status type  Community acquired pneumonia, unspecified laterality Acute metabolic encephalopathy Metabolic encephalopathy    HOSPITAL COURSE: 80-year-old female with medical history of dementia, AFib, CKD, chronic obstructive pulmonary disease, CHF, type 2 diabetes presented to the hospital with shortness of breath and altered mental status.  Patient is from skilled nursing facility with reported deterioration in mentation over the last several days.  As a result patient was brought into the emergency department.  Patient presented tachypneic requiring BiPAP on arrival.  Patient was found to have leukocytosis, and elevated BNP.  Procalcitonin was within normal limits.  Troponins were elevated but overall somewhat flat.  Septic workup was initiated.  Chest x-ray did not show any signs of pneumonia.  No effusions or pneumothorax was also appreciated.  Patient was started on cap coverage and given a dose of Solu-Medrol.  Patient's viral testing did eventually come back positive for COVID-19.  Steroids were transitioned to Decadron.  Additionally patient found to have urinary tract infection likely contributing to current altered mental status.  Was treated with ceftriaxone and eventually transitioned to Ceftin.  Breathing did improve as patient was able to wean off of the BiPAP back to room air.  Antibiotics were eventually discontinued with patient doing well with steroids.  Patient is now currently breathing at her baseline and mentating at baseline as per family at bedside.  Patient will be discharged back to skilled nursing facility and finish off course of steroids and antibiotics
Breastfeeding; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of EXPOSURE VIA BREAST MILK (Breastfeeding) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPOSURE VIA BREAST MILK (Breastfeeding). At the time of the report, EXPOSURE VIA BREAST MILK (Breastfeeding) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.; Sender's Comments: This is a case of product exposure during breastfeeding with no associated AEs. Patient will continue to be contacted for further monitoring of AEs.
This case was reported by a nurse via call center representative and described the occurrence of pre-existing condition improved in a female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included breast cancer stage iv (stage 4 lobular breast cancer). On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, 8 days after receiving SHINGRIX, the patient experienced pre-existing condition improved and unexpected therapeutic effect. On an unknown date, the outcome of the pre-existing condition improved and unexpected therapeutic effect were unknown. It was unknown if the reporter considered the pre-existing condition improved and unexpected therapeutic effect to be related to SHINGRIX. Additional details were provided as follows: The patient experienced circulating tumor cell (CTC) count decreased to zero 8 days after receiving SHINGRIX. Prior test results had been consistent (2, 2, 3, 3 and 4). The reporter was oncology nurse reported that a patient with stage 4 lobular breast cancer who recently had a CTC (Circulating Tumor Cell) count of zero after nearly 8 months of elevated (and persistently rising CTC counts (starting in Sept 2018 values obtained every 6 to 8 weeks, on capecitabine, were 2, 2, 3, 3, 4.) The very unexpected result of zero was from a lab specimen obtained 8 days after the first dose of the SHINGRIX vaccine. The reporter asked that the vaccine's stimulation of the CD4 T cells be involved with either a false suppression of circulating tumor cells, adversely affect the test process or be an actual reduction of live CTCs Or was it more likely that this was a coincidence.
ringing in my ears/head and it's constant; I also seem to have an inflammatory response in my upper back; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unknown date, the patient experienced ringing in my ears/head and it's constant (tinnitus) and i also seem to have an inflammatory response in my upper back (inflammation). It's been 11 days now and there is no resolution. The clinical outcome for the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.  Follow up (14Apr2021): This is an Spontaneous report from a contactable consumer. This is a female consumer (patient) reported for herself that:  No new information received.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Exactly one week after the vaccine, the injection sight developed a hard lump about 1? in circumference and was uncomfortable.  The next day the lump was 3x larger and my arm was so swollen it was hard to raise.  It was red, hot and very achy all throughout the muscle in my upper arm and stayed like that for 24 hours.    My allergies turned to cold symptoms/headaches and have not improved since.
child mom reports left clinic about 1230PM;pt fell asleep on way home & mom put pt in bed upon arriving home;mom heard pt moving around went to check & found pt shaking all over, hands & feet were blue & couldn't rouse pt;t101;to ER t102 R;
I started experiencing a fever and fatigue that evening. Shortness of breath. Upset stomach, severe pain. Following night completely fine. Felt as though I had a 24hr COVID virus.
Patient fretful with decreased appetite for 2 days. No relief with Tylenol. Mom states can't put infant down. Decision was made to withhold pertussis in the future.
No effect for approx. 6-weeks; then, headache, complete body fatigue and muscle weakness developed overnight.   A "charged-nerve"/anxious-energy feeling developed throughout body.  Then- over the next couple-weeks- numbness in hands/fingers, feet/toes, tremors in head, neck, face hands and fingers and shakiness in arms and legs, developed and continue until today.  The headache and charged-nerve feeling has continued, and pain in neck and mid/lower-spine has developed.  Muscles in legs especially continue to be weak and some pain has developed in thighs.  A ringing in ears is continuous and fasciculations have developed throughout entire body.
Gradually lost cognitive ability, unable to stay awake, headaches, muscle and joint pains, unable to work and handle personal affairs, vertigo, SOB, and on and on. Medical Records received on 1/26/2005 states pt experienced fatigue, Raynaud's phenomena, insominia, hypersominia/narcolepsy, Lyme encephalopathy, night sweats since stopping hormones, and  IBS-Irritable Bowel Syndrome. Follow up: Chronic Lyme disease triggered by Lymerix, diagnosis given to pt approx May04. Note: Dose #1 Lymerix given 4/23/99 LY120G9. Follow up 02/02/05: lot number for vaccine number 1 is unknown. Per follow up report-Unable to work, extreme physical and mental fatigue. Pain and discomfort, insomnia, loss of intellect
joint pain to hip and knee; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint pain to hip and knee) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 036B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced ARTHRALGIA (joint pain to hip and knee). At the time of the report, ARTHRALGIA (joint pain to hip and knee) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-098256 (Patient Link).
Weds April 7th at 2 p.m. at the  fairgrounds I was given the J & J 1 dose shot by retired Dr.  The second the shot went in I felt extremely light headed and felt like I was going to pass out.  They got me by both arms and got me in a wheelchair and wheeled me to recovery with 30 minute wait.  The staff member at recovery asked me if I had eaten anything that day.  I had not eaten anything by 2 p.m. in the afternoon.  They gave me apple juice and I instantly felt better.  The next morning starting at 8 a.m. 1" welt at pin needle site on left arm, low grade headache all day, nauseous all day, tired.  At 4:30 p.m. the next day Thursday, 4/8/2021 I went to sleep at 4:30 p.m. and slept until 8 a.m. Friday morning 4/9/2021.  Friday, 4/9/2021 I feel pretty good today.
Pt was at doctor for normal visit when she noticed her arm was red and swollen and very painful. she drew a line around the spot the was about the size of her hand and it did get bigger md said it was clearly infected and wanted to give meds but pt refused to see how it would do and it has finally started to come down.
The COVID-19 vaccine administered through vaccine administrator, between June 25 and July 30 came from the lot number 039K20A.  It was discovered that this particular lot was beyond its frozen expiration date by five (5) up to forty (40) days. A case was opened with Moderna (Case #: MOD21-126790). Please refer to this case number if you would like to contact Moderna directly. Moderna confirmed that the vaccine doses administered maintained the activity necessary to protect against the COVID-19 virus. Moderna also confirmed there is no danger to anyone's health from receiving a vaccine past its frozen expiration date. No adverse reactions were identified.
pt had a positive COVID test on 8/3/21; 8/31/22 pt to ED after a MVA with AMS; pt had a PE; suffered cardiac arrest; ROSC achieved; transferred to ICU; intubated; anemic; given 2 units PRBCs; suffered bradycardia and cardiac arrest; ROSC achieved; pneumothroax requiring chest tube; pt suffered cardiac arrest again; family made pt a DNR and he passed away in the hospital; records state PE likely secondary to previous COVID infection
Patient was given 0.5mg of Moderna vaccine instead of 0.25mg, there was no adverse reaction per patient, patient was called and also a letter was sent.
Patient at  COVID Vaccination Clinic.  Patient received a Moderna first dose on 3/11 and was back at for their second dose on 4/8. The patient ended up receiving a dose of Pfizer for their second dose rather than Moderna. Failure at multiple steps leading up to wrong vaccine given: 1. General Registration: Looked patient up on Moderna schedule, put gave Pfizer wristband (Purple) rather than Moderna wristband (Red). 2. At rover check in there is a question that asks if a patient has received a 1st vaccine dose and what type of vaccine it was. The volunteer selected "Yes" they patient had received the first dose and that it was Pfizer. 3. Registration checked patient in and the vaccine type was not confirmed and checked against the wristband color. 4. At the vaccine table there is a vaccine administer and someone else documenting. The patient gave their vaccine card to the documenter while the vaccine administer gave the vaccine. The vaccine was given before the documenter pulled up the patient and scrolled to the bottom to realize that Moderna was the only choice. For second doses, Epic only allows a second dose type that is the same as the first dose to avoid these situations. The student that administered the vaccine, should have been confirming the vaccine type on the vaccine card before administering the vaccine. To mitigate the risk of this issue occurring in the future, we have re educated staff/volunteers at all steps of the process. We are confident that if the vaccine administer was a more experience clinician, this would have been avoided; more experienced clinicians would know to confirm the patient/medication match the medication being given. This was the first medication error at the clinic in over 32000 visits.
Multiple pulmonary emboli.  Pt had symptoms start, mild lower rib, upper abdominal pain start 1 week after first dose, worsening after second dose prompting her to seek care.  Multiple PE diagnosed later in the day on 8/11
Headache the next morning after receiving vaccine that hasn?t gone away, fluid in left lung, blood clots in right lung and leg.
Fever; Chills; Headache; Fatigue; This is a spontaneous report received from contactable reporter(s) (Other HCP) from a sales representative. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "Fever"; CHILLS (non-serious), outcome "unknown"; HEADACHE (non-serious), outcome "unknown"; FATIGUE (non-serious), outcome "unknown".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
heart problems; This is a spontaneous report from a contactable consumer (not the patient) via telephonic activity. A 43-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (batch/lot number was not reported) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for COVID-immunization. The patient experienced heart problems (seriousness criteria: death, medically significant) on an unspecified date. The patient died on an unspecified date. It was not reported if an autopsy was performed.  The lot number for the BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), was not provided and will be requested during follow up.; Reported Cause(s) of Death: heart problems
This spontaneous report was received from the registered nurse refers to an unknown number of patients of unknown age and gender. On an unknown date, the patient was vaccinated with RECOMBIVAX HB (dose, route and lot were not reported). On an unknown date, the patients received improperly stored RECOMBIVAX HB. No adverse symptoms reported. At the time of the report the action taken was not reported. All telephone attempts to obtain follow-up information have been unsuccessful. Follow up information was received from a registered nurse concerning a neonate male patient. On 17-JUL-2014 at 22:39 the patient was vaccinated with the first dose of RECOMBIVAX HB lot # J012520, expiration date: 30-JAN-2016, intramuscular. The storage temperature of RECOMBIVAX HB was between 0 and 1 degrees, on 18 different episodes between 14-MAY-2014 and 21-JUL-2014. The registered nurse reported that it was no possible to identify how long the temperatures were down because it was not documented accordingly, since all recorded temperatures by morning and by night were within 2 and 8 degrees. It was reported that the vaccine was removed once the problem was identified and it had not been used after 21-JUL-2014. There were no adverse events reported since all follow ups requested to complete the case were received. This is one of several reports received from the same source. Additional information is not expected.
02/20/2021 Immediate post-vaccination onset of intermittent lightheadedness & migrating sensation of tingling over body & face; at 45 minutes also experienced a sequence of coldness of feet, then hands (w/decreased perfusion), as those resolved then core/trunk, as trunk warmed then at 75 min upper gums, then eyelids, then nose; bowel urgency; at 2 hours warm flush, mind clearer, better color vision, feeling stronger; lightheadedness resolved within 3 hours of pharmacist observation. No urticaria, angioedema or respiratory distress. No treatment. Could stand and walk with assistance, though very fatigued. Rested at home. **Re-presentation of lightheadedness & tingling on 02/22 & again mildly on 02/24 while resting.**
Post-vax the patient developed a low grade fever and screamed non-stop day and night for 3 days. Sometimes the scream was high pitched. He would stiffen his arms and legs, shake his arms and turn red in the face. There was slight redness at the injection site, and no swelling. The patient was initially fussy right after the injections.
Cough     they told her to come here because she doesn't speak English. Pt has a cough with phlegm. Has not been tested for covid.      HPI a 61 y.o. female who presents to the ED after going to an urgent care for complaints of cough with mucus production. All communication with the patient was performed with Google Translator. Patient denies any past medical history. Patient states her cough has been present for the past 3 days and she has been producing white sputum. She denies any fevers, nausea, vomiting, chest pain, or shortness of breath. Patient denies any sick contacts. Patient admits to neck soreness and sore throat that began with the cough 3 days ago. She has no history of smoking or smoke exposure.
Onset sixteen (16) hours after injection: Vomiting, Joint Stiffness, Muscle Pain, severe headache, difficulty standing, walking, and bending at the waist.
Started getting general ill feeling, losing weight, within two months lost 20 lbs, lymphnodes swelled everywhere.
burning on left side in back, tightness in esophagus, tender left side of breast
presented 2/5 with altered mental status and acute hypoxic respiratory failure and septic shock secondary to bacterial pneumonia complicated by L pneumothorax and E coli /Klebsiella urinary tract infection. She required intubation upon arrival, was started on broad spectrum antibiotics and chest tube was placed for L pneumothorax. Patient was also found to be COVID +. Patient continued to deteriorate and she developed nonsustained wide complex tachycardia. Family was updated and expressed the patient would have wanted to be made comfort given her current clinical status. Comfort care measures were initiated and after compassionate extubation, patient ultimately passed at 1308 on 2/6/22. Med Tx: maxipime, vanc,
Seizures (4).   Child had 3 seizures at home with parents. Taken to the hospital, transported to hospital. Seizure event was witnessed by hospital staff/physician.  Child was monitored. Received an MRI, EEG, and anti -seizure meds. Administered the next round of vaccines "later" than usual, and isolated them (1 at a time).
12/01/2021- 2:00 pm fever and facial swelling of ear and Cheek extending down to the neck on left side of face , with redness and pain. 5:00 pm Hard to breathe, wheezing. Epi-pen administration at 5:35, became easier to breath but still had a heavy/fullness feeling in chest and couldn?t take a deep breath. Facial pain was intensified and now burning sensation, swelling had gone down with dose of Epi-pen. 6:20 pm went  to Emergency Room  - given breathing treatment and pain medication  after breathing treatment heavy chest was relieved but not resolved.
Slight fever, diminished appetite, hard to arouse when sleeping, and unable to move infant without her crying (discomfort).
No adverse symptoms reported.; Nurse reported that the patient was "inadvertently administered an expired dose of ZOSTAVAX"; This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not reported.  On 16-JUN-2020, the patient was inadvertently administered an expired dose of zoster vaccine live (ZOSTAVAX) (dose, route of administration, vaccination scheme and anatomical site of vaccination, were not reported; lot number N013274, which has been verified to be valid, expiration date reported and valid as 04-JUL-2018) as prophylaxis. No additional adverse effects were reported.
There was a young lady before me who was in pain after her vaccine and said "my arm, my arm" as she held it.  I was hoping I wouldn't get the same person, I did.  As she was giving me my shot, I said, "owe that hurt", fairly loud, couldn't help it, it hurt.  I had never had a shot hurt like that before.   I don't know exactly when the painful range of motion was first noticed - but fairly soon after - maybe a day or two? However, the injection site hurt from the time she gave me the shot until now.  I can feel where the shot went into my arm when I press on the area.   There is a deep ache in my upper right arm when ever I do certain motions - sometimes the ache lasts 3-5 seconds and is very painful.  I have decreased ROM in probably every direction - depending on the position of my hand (thumbs up, palm up or palm down).   I haven't done much treatment as of yet due to I keep thinking surely this has to go away, but it hasn't.  I have gone to my husband twice for he is a chiropractor - but will have him treat it more now, since it hasn't gone away.  I have treated it myself with hot packs, trigger point therapy, stretches, but nothing is helping.  I have had a degree as a Physical Therapist Assistant so know some exercises and can use our therapy's at our clinic.  I have looked online to see what treatment can be done and there is nothing a medical doctor can do from what I can see, but give medications or surgery from the sounds of things and I don't want either of those, so one reason why I haven't gone to a medical doctor.  I will do all I can naturally to fix it.  I was treated once last year and once currently for my arm and I have done self care in between.